Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101075
Status:
TERMINATED
Last Update Posted:
2017-02-27
First Post:
2005-01-07
Brief Title:
Title XELOX FOR SALIVARY GLAND CANCERS
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| high-grade salivary gland mucoepidermoid carcinoma | View |
| low-grade salivary gland mucoepidermoid carcinoma | View |
| salivary gland acinic cell tumor | View |
| salivary gland adenocarcinoma | View |
| salivary gland adenoid cystic carcinoma | View |
| salivary gland malignant mixed cell type tumor | View |
| salivary gland poorly differentiated carcinoma | View |
| salivary gland squamous cell carcinoma | View |
| recurrent salivary gland cancer | View |
| stage III salivary gland cancer | View |
| stage IV salivary gland cancer | View |